Raha Samraat S. 4
4 · MYRIAD GENETICS INC · Filed Dec 2, 2024
Insider Transaction Report
Form 4
Raha Samraat S.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-11-30$13.83/sh+1,118$15,462→ 301,972 total
Footnotes (1)
- [F1]These shares were acquired under the Myriad Genetics, Inc. 2012 Amended and Restated Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).